Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials

被引：56

作者：

Choi, I. ^{[2
]}

Tanosaki, R. ^{[3
]}

Uike, N. ^{[2
]}

Utsunomiya, A. ^{[4
]}

Tomonaga, M. ^{[5
]}

Harada, M. ^{[6
]}

Yamanaka, T.

Kannagi, M. ^{[7
]}

Okamura, J. ^{[1
]}

机构：

[1] Kyushu Natl Canc Ctr, Inst Clin Res, Minami Ku, Fukuoka 8111395, Japan

[2] Kyushu Natl Canc Ctr, Dept Hematol, Fukuoka 8111395, Japan

[3] Natl Canc Ctr, Stem Cell Transplantat Unit, Tokyo, Japan

[4] Imamura Bun In Hosp, Dept Hematol, Kagoshima, Japan

[5] Nagasaki Univ, Mol Med Unit, Dept Hematol, Atom Bomb Dis Inst,Sch Med, Nagasaki 852, Japan

[6] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan

[7] Tokyo Med & Dent Univ, Div Med Res, Dept Immunotherapeut, Tokyo, Japan

来源：

BONE MARROW TRANSPLANTATION | 2011年 / 46卷 / 01期

基金：

日本学术振兴会;

关键词：

adult T-cell leukemia/lymphoma; allogeneic hematopoietic SCT; reduced-intensity conditioning regimen; HTLV-1 proviral load; RETROSPECTIVE ANALYSIS; LEUKEMIA-LYMPHOMA; TRANSPLANTATION; INTENSITY; IMPACT;

D O I：

10.1038/bmt.2010.92

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

We have previously conducted clinical trials of allogeneic hematopoietic SCT with reduced-intensity conditioning regimen (RIC) for adult T-cell leukemia/lymphoma (ATLL)-a disease caused by human T-lymphotropic virus type 1 (HTLV-1) infection and having a dismal prognosis. Long-term follow-up studies of these trials revealed that 10 of the 29 patients have survived for a median of 82 months (range, 54-100 months) after RIC, indicating a possible curability of the disease by RIC. However, we have also observed that the patterns of post-RIC changes in HTLV-1 proviral load over time among the 10 survivors were classified into three patterns. This is the first report to clarify the long-term outcomes after RIC for ATLL patients. Bone Marrow Transplantation (2011) 46, 116-118; doi:10.1038/bmt.2010.92; published online 19 April 2010

引用

页码：116 / 118

页数：3

共 10 条

[1] Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma [J].

Fukushima, T ;

Miyazaki, Y ;

Honda, S ;

Kawano, F ;

Moriuchi, Y ;

Masuda, M ;

Tanosaki, R ;

Utsunomiya, A ;

Uike, N ;

Yoshida, S ;

Okamura, J ;

Tomonaga, M .

LEUKEMIA, 2005, 19 (05) :829-834

[2] Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma [J].

Kami, M ;

Hamaki, T ;

Miyakoshi, S ;

Murashige, N ;

Kanda, Y ;

Tanosaki, R ;

Takaue, Y ;

Taniguchi, S ;

Hirai, H ;

Ozawa, K ;

Kasai, M .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (02) :304-309

[3] Allogeneic bone marrow transplantation from unrelated human T-Cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: Retrospective analysis of data from the japan marrow donor program [J].

Kato, Koji ;

Kanda, Yoshinobu ;

Eto, Tetsuya ;

Muta, Tsuyoshi ;

Gondo, Hisashi ;

Taniguchi, Shuichi ;

Shibuya, Tsunefumi ;

Utsunomiya, Atae ;

Kawase, Takakazu ;

Kato, Shunichi ;

Morishima, Yasuo ;

Kodera, Yoshihisa ;

Harada, Mine .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (01) :90-99

[4] Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma [J].

Okamura, J ;

Utsunomiya, A ;

Tanosaki, R ;

Uike, N ;

Sonoda, S ;

Kannagi, M ;

Tomonaga, M ;

Harada, M ;

Kimura, N ;

Masuda, M ;

Kawano, F ;

Yufu, Y ;

Hattori, H ;

Kikuchi, H ;

Saburi, Y .

BLOOD, 2005, 105 (10) :4143-4145

[5] DIAGNOSTIC-CRITERIA AND CLASSIFICATION OF CLINICAL SUBTYPES OF ADULT T-CELL LEUKEMIA-LYMPHOMA - A REPORT FROM THE LYMPHOMA-STUDY-GROUP (1984-87) [J].

SHIMOYAMA, M .

BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 (03) :428-437

[6] A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): Clinical impact of graft-versus-leukemia/lymphoma effect [J].

Shiratori, Souichi ;

Yasumoto, Atsushi ;

Tanaka, Junji ;

Shigematsu, Akio ;

Yamamoto, Satoshi ;

Nishio, Mitsufumi ;

Hashino, Satoshi ;

Morita, Rena ;

Takahata, Mutsumi ;

Onozawa, Masahiro ;

Kahata, Kaoru ;

Kondo, Takeshi ;

Ota, Shuichi ;

Wakasa, Kentaro ;

Sugita, Junichi ;

Koike, Takao ;

Asaka, Masahiro ;

Kasai, Masaharu ;

Imamura, Masahiro .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (07) :817-823

[7] HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking [J].

Sonoda, J ;

Koriyama, C ;

Yamamoto, S ;

Kozako, T ;

Li, HC ;

Lema, C ;

Yashiki, S ;

Fujiyoshi, T ;

Yoshinaga, M ;

Nagata, Y ;

Akiba, S ;

Takezaki, T ;

Yamada, K ;

Sonoda, S .

CANCER SCIENCE, 2004, 95 (07) :596-601

[8] Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: Impact of Antithymocyte globulin on clinical outcome [J].

Tanosaki, Ryuji ;

Uike, Naokuni ;

Utsunomiya, Atae ;

Saburi, Yoshio ;

Masuda, Masato ;

Tomonaga, Masao ;

Eto, Tetsuya ;

Hidaka, Michihiro ;

Harada, Mine ;

Choi, Ilseung ;

Yamanaka, Takeharu ;

Kannagi, Mari ;

Matsuoka, Masao ;

Okamura, Jun .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (06) :702-708

[9]

Thiede C, 1999, BONE MARROW TRANSPL, V23, pS50

[10] Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation [J].

Utsunomiya, A ;

Miyazaki, Y ;

Takatsuka, Y ;

Hanada, S ;

Uozumi, K ;

Yashiki, S ;

Tara, M ;

Kawano, F ;

Saburi, Y ;

Kikuchi, H ;

Hara, M ;

Sao, H ;

Morishima, Y ;

Kodera, Y ;

Sonoda, S ;

Tomonaga, M .

BONE MARROW TRANSPLANTATION, 2001, 27 (01) :15-20

← 1 →